Actively Recruiting
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
Led by Peking University Cancer Hospital & Institute · Updated on 2024-11-25
20
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with lung lesions.
CONDITIONS
Official Title
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years, male or female
- Normal heart function
- Estimated survival of at least 12 weeks
- Good follow-up compliance
- At least one measurable target lesion according to RECIST1.1 criteria
- Women of childbearing age (15-49 years) must have a negative pregnancy test within 7 days before starting the test
- Fertile men and women must agree to use effective contraception during the study and for 3 months after
- Recommended by clinicians to undergo PET/CT for tumor diagnostic staging
- Ability to understand and voluntarily participate with signed informed consent
You will not qualify if you...
- Serious abnormalities of liver, kidney, or blood
- Pregnant patients
- Lactating women
- Unable to lie flat for half an hour
- Refusal to participate in the clinical investigation
- Claustrophobia or other mental diseases
- Other conditions deemed unsuitable by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Cancer Hospital & Institute
Beijing, Beijing Municipality, China, 100142
Actively Recruiting
Research Team
N
Nan Li
CONTACT
X
Xin Zhou, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here